| A division of Genzyme Corporation, Genzyme
Molecular Oncology is developing a new generation of cancer products focusing on cancer
vaccines and angiogenesis inhibitors. It is shaping these new therapies through the
integration of its gene discovery, gene therapy, small-molecule drug discovery, and
protein therapeutic efforts. Genzyme Molecular Oncology has its own common stock intended
to reflect its economic value and track its performance. |
